Research
We are harnessing the power of mRNA to create a new category of medicines and a company that maximizes its impact on human health. We are currently focusing on the development of vaccines and therapeutics across infectious diseases, cancer and rare diseases.
What is a modality?
When we identify technologies that we believe could enable a new group of potential mRNA medicines with shared features, we call that group a modality. While the programs within a modality may target diverse diseases, they share similar mRNA characteristics, delivery technologies and manufacturing processes.
Moderna's modalities
Infectious disease vaccines
Systemic secreted and cell surface therapeutics
Cancer therapies
Intratumoral immuno-oncology
Localized regenerative therapeutics
Systemic intracellular therapeutics
Inhaled pulmonary therapeutics
We have created seven modalities to date, but we are relentlessly working to grow this number as we discover mRNA medicines.
Therapeutic Areas
Infectious diseases
The world needs novel, innovative approaches to address both known and future infectious disease threats.
Immuno-oncology
We are harnessing the body’s immune system to identify and kill cancer cells in the same way the immune system identifies and targets infections.
Rare diseases
Moderna recognizes the impact of rare diseases on patients and their families, particularly when the disease lacks any effective treatment options.
Research fellowship
We are pleased to offer the opportunity to support research fellowships in order to further research in the area of mRNA medicines, as well as in disease areas currently under investigation by Moderna.
Want to learn more?
For more detailed information on the programs in Moderna’s pipeline, click below.